Evidence-led guide Clinical review pending · 10 October 2026

Six claims, a closer look

Six creatine myths
women still hear.

“Only for men.”

The research includes women, too. See the review ↗

Some claims are unsupported. Others need context. Here’s what the studies found, who they included and where the questions remain.

Last checked 10 October 2026 · 5 sources · Clinical review pending

Myth 01

“Creatine makes you fat.”

Does creatine increase body fat?

Not shown.

The research reviewed in 2021 did not support an increase in fat mass with creatine. Water changes can affect scale weight, but that is a different outcome. If weight is your main concern, the more useful question is what a study actually measured and who took part. Source ↗

What should I keep in mind?

A review brings together different studies. It cannot promise how one person’s weight will change. Read the evidence ↗

Read the full answer ↗

Myth 02

“Creatine makes your hair fall out.”

Does creatine cause hair loss?

Not in this trial.

A 2025 trial found no significant difference in hair outcomes between creatine and placebo over 12 weeks. It studied resistance-trained men, with hair measurements available for 37 participants. This is useful direct evidence, but it does not settle long-term effects or establish the same result in women. Source ↗

What should I keep in mind?

The trial involved men and lasted 12 weeks. It cannot establish long-term outcomes or an equivalent result in women. Read the evidence ↗

Read the full answer ↗

Myth 03

“You have to load first.”

Do you need a loading phase?

Optional.

A loading phase is one way to raise muscle creatine stores more quickly. The ISSN position stand also describes a gradual approach using lower daily amounts. Maintenance protocols commonly use 3 to 5 g a day. These are research approaches to understand, rather than a personalised dose recommendation. Source ↗

What should I keep in mind?

The position stand describes 3 g a day for around 28 days as a slower approach. Individual circumstances still matter. Read the evidence ↗

Read the full answer ↗

Myth 04

“The research is all in men.”

Has creatine safety been studied in women?

Yes.

A 2020 review brought together 29 studies monitoring adverse outcomes in 951 female participants. It found no serious adverse events attributed to creatine in those studies. Reporting was uneven, though, and the findings cannot establish safety in every medical situation, at every dose or over an unlimited time. Source ↗

What should I keep in mind?

Clinical review of this guide is pending. For an individual decision, particularly with a medical condition or during pregnancy or breastfeeding, discuss supplements with your GP. Read the evidence ↗

Read the full answer ↗

Myth 05

“A newer form must be better.”

Is another form better than monohydrate?

Not established.

Creatine monohydrate is the form most extensively studied in the reviewed research. A different name or a higher price does not, by itself, show a better result. Comparisons need evidence using the actual formulation and outcome being claimed, rather than assuming all forms have the same research behind them. Source ↗

What should I keep in mind?

Look for a direct comparison with monohydrate. Evidence from one formulation cannot automatically establish another formulation’s effects. Read the evidence ↗

Read the full answer ↗

Myth 06

“Creatine improves bone density.”

Does creatine improve bone density after menopause?

Not in this trial.

A two-year trial in 237 postmenopausal women found no improvement in bone mineral density with creatine compared with placebo. Both groups followed an exercise programme. Some bone geometry measures improved, but those results are different from a density improvement and do not show that fractures became less likely. Source ↗

What should I keep in mind?

The primary outcome was femoral-neck bone mineral density. Positive secondary findings should not hide a negative primary result. Read the evidence ↗

Read the full answer ↗

Two studies worth opening

What did these trials actually measure?

The hair trial measured hair outcomes directly. The bone trial measured bone density and other bone properties. Their populations and timeframes differ, so we show those details alongside the findings. Read a paper’s main outcome before treating a positive secondary result as the whole story.

Randomised trial2025

Lak et al., 2025

No significant difference in hair outcomes or DHT between creatine and placebo.

Who
Resistance-trained men aged 18 to 40; 38 completers, 37 with hair assessments
Dose
5 g/day
Duration
12 weeks
Limits
Men only, small sample and 12 weeks. This does not establish long-term effects in women.
Read the published paper (opens in a new tab)
Randomised trial2023

Chilibeck et al., 2023

No added bone-density or measured strength benefit; selected bone-geometry measures and walking time favoured creatine.

Who
237 postmenopausal women, mean age 59, randomised
Dose
0.14 g/kg/day
Duration
2 years
Limits
Both groups exercised. Lean-mass benefit appeared in a valid-completers subanalysis. Secondary bone geometry findings are not proof of fewer fractures.
Read the published paper (opens in a new tab)